Concurrent Symposia Sessions

Wednesday, October 7, 2009
Natcher Conference Center
Symposia Session II
Balcony C

Co-Chairs: David FitzGerald, NCI and Mitchell Ho, NCI

Antibodies are important agents for both the therapy and diagnosis of human disease. Therapeutic antibodies are currently used in the treatment of cancer, infectious disease and inflammatory processes. Advances in antibody engineering are aimed at improving early generation antibodies and by using recombinant techniques, display selections and mutagenesis, it is hoped to generate antibodies with more desirable properties.

Program

Presentation by FARE Award Winner
Affect of Bevacizumab on Glioblastoma Vascularity as Assessed with Dynamic Contrast-enhanced MRI
Weiting Zhang, NCI

Introduction
David FitzGerald, NCI

Recombinant Immunotoxins for Treating Cancer
Ira Pastan, NCI

Engineered Antibody Domains as Candidate Therapeutics
Dimiter Dimitrov, NCI

Antibodies that Neutralize Cytokines
Warren Strober, NIAID

Human Monoclonal Antibodies to Mesothelin
Mitchell Ho, NCI